buy

BioMarin Pharmaceutical Inc. buy Morgan Stanley

BioMarin Pharmaceutical Inc.

Start price

€46.90

/ 50%

Target price

28.10.26

Performance (%)

Price

Summary

This prediction is currently active. The prediction currently has a performance of . This prediction currently runs until 28.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
BioMarin Pharmaceutical Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Morgan_Stanley for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 84.064

Change

Ends at

BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Morgan Stanley from $104.00 to $98.00. They now have an "overweight" rating on the stock.

Ratings data for BMRN provided by MarketBeat

Morgan Stanley